Overview of Signant Health’s Brexit Planning
December 31, 2020 marks the end of the Brexit transition period and the change to existing arrangements for the movement of goods between the United Kingdom’s (UK) and European Union (EU).
Signant Health has proactively reviewed and tested various shipping and import/export solutions to optimize the support we provide and implemented processes and standards to ensure seamless business continuity.
We have also modeled and tested plans to minimize disruption due to potential Brexit issues and created a plan in the event the UK exits the transition period without an agreement with the EU.
This is a dynamic situation, and details are likely to change rapidly as the end of the transition phase approaches.
To learn more about the specifics of Signant Health’s Brexit planning, please contact your Signant Health representative directly or email Brexit@SignantHealth.com.